We still know remarkably little about why renal function in many chronically-diseased human kidneys continues to decline at a predictable rate over time. If patients whose renal function is likely to decline can be diagnosed early, effective measures to slow the rate of progression could be introduced before irreversible renal scarring occurs. Three such predictive factors have emerged. Firstly, the preservation of the tubulointerstitium rather than the glomerulus appears to be the major histological determinant of renal outcome in a wide variety of classical glomerulopathies [1] . Secondly, the extent of the interstitial infiltrate (which consists largely of T cells and macrophages) correlates well with the degree of functional impairment and is a good predictor of long-term prognosis [2] . Thirdly, the magnitude of proteinuria appears to correlate positively with the rate of progression in patients with impaired glomerular filtration rates according to preliminary results from the large multicentre 'Modification of Renal Disease by Diet' study [3] . No doubt, controversy will continue to rage over the pathogenic potential of filtered plasma proteins since direct in-vivo evidence of this, in the absence of other potentially relevant factors such as changes in glomerular function, has not yet been obtained [4] , It seems possible though that, in addition to filtered albumin, larger non-albumin proteins such as lipoproteins [5] might prove to be 'tubulo-toxic' and thus provide a convenient link between primary glomerular injury and secondary tubular injury.
Predicting progression
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Tubular injury and tubular-derived cytokines
It has become apparent that renal tubular cells derived from various species, including man, synthesise a whole host of cytokines, including vasoactive factors, e.g. endothelins, nitric oxide, chemotactic cytokines, complement proteins and polypeptide growth factors which appear to have little to do with transport functions [reviewed in 6]. We still know very little about the normal physiological roles or targets for most of these compounds in the kidney. However, there appears to be specific segment localisation (e.g. EGF) and celltype-specific gene regulation as recently described for tubular-derived endothelins [7] . In a recent review [6] , we proposed that tubular injury due to ischaemia or to overload with filtered proteins could result in tubulointerstitial injury if injured tubular cells became 'dysfunctional'. Such dysfunctional cells could overproduce matrix components and paracrine growth factors (leading to fibroblast proliferation and matrix accumulation), chemotactic cytokines (leading to a chronic inflammatory cell infiltrate) and vasoactive factors (leading to ongoing ischaemia). Each of these consequences could then magnify and exacerbate the initial injury, thus setting up a self-perpetuating cycle of injury, leading to obliteration of the peritubular capillaries [1] .
Evidence from human renal tissue
Although most of the evidence in support of the above hypothesis derives from in-vitro studies, there is early in-vivo human evidence to support these views. In one study of patients with chronic renal allograft rejection, a condition characterised by tubulointerstitial pathology, increased receptor sites for PDGF overlying interstitial cells were found [8] . In another study of patients with a variety of glomerulopathies, tubular expression of IL-6 appeared to be highest in atrophic tubules [9] . An important study published recently showed that gene expression of the complement protein C3 in a variety of human renal diseases correlated significantly with the presence of tubulointerstitial pathology and inflammatory cells present on renal biopsy [10] . However since proximal tubular cells are only one cell type among several that secrete C3, it remains to be seen whether tubular C3 is crucial in the pathogenesis of tubulointerstitial disease.
In conclusion, the link between tubular injury, proteinuria, tubular-derived cytokines, interstitial cell infiltrate and tubulointerstitial pathology in the pro-gression of human renal disease is becoming quite convincing. Several crucial questions however, remain to be answered: Can tubular cell dysfunction which does not lead to cell death be experimentally defined? Which, if any, of the non-albumin plasma proteins are tubulo-toxic and how is this toxicity mediated? In appropriate animal disease models, can disease pathology be altered by blocking the synthesis or action of individual cytokines? What tissue-specific factors regulate gene expression of individual cytokines, given their widespread distribution? Can changes in tubular cytokine expression in-vivo be related to specific tubulointerstitial pathologies in different human diseases? A clarification of these issues should lead to a better understanding of the process of renal disease progression in man.
